All Articles

A surge of investment and promising new therapies are transforming the spasticity treatment landscape, with a projected $9.6 billion market opportunity by 2030. Explore the key players and pipeline drugs poised to reshape care for millions.

A new report analyzes the burgeoning Gaucher disease clinical trial landscape, revealing growth opportunities for investors and hope for patients with this rare genetic disorder. Gene therapy and novel treatments are driving innovation.

A surge in R&D is reshaping the diabetic retinopathy treatment landscape, with a robust pipeline of novel therapies poised to address limitations of current anti-VEGF treatments and improve patient outcomes.

New data reveals a potential slowdown in biomarker adoption for clinical trials. Is this a temporary shift, or a sign of deeper challenges hindering personalized medicine's progress? We dive into the trends and implications.

New research highlights a burgeoning pipeline of therapies targeting cancer cachexia, a debilitating syndrome affecting millions. Investment is rising as innovative approaches move closer to market, offering potential relief for patients and growth opportunities for the industry.

Zoo Knoxville’s new immersive light and sound show, ‘Smoky Night Lights,’ isn't just entertainment—it's a bold move toward diversification, tech integration, and a deeper connection with the natural world.

Thermo Fisher Scientific is aggressively expanding its digital footprint through strategic acquisitions and AI integration, solidifying its dominance in the life sciences and clinical research sectors. A deep dive into the company's transformation strategy.

From low-emission wires to AI-powered robotics, the welding industry is undergoing a transformation fueled by demand, stricter regulations, and a focus on efficiency and worker safety. A deep dive into the latest trends.

Mining companies are betting big on artificial intelligence, with projected spending reaching $13.1 billion by 2029. This investment is driving a wave of innovation in safety, efficiency, and sustainability across the sector.

The arc welding market is undergoing a rapid transformation, driven by inverter tech, IoT connectivity, and a growing demand for sustainable practices. A deep dive into the trends shaping the future of joining technologies.

New regulations in India and centralized procurement in China are driving significant changes in the pharmaceutical landscape, impacting supply chains, pricing, and investment strategies across emerging markets.

Venture capital investment in the pharmaceutical sector hit $5 billion in Q3 2025, driven by oncology's continued dominance. Investors are prioritizing de-risked assets and later-stage companies with robust clinical data.

A new report signals growing investment in social anxiety disorder (SAD) research, with clinical trials expanding globally. We examine the market trends, pipeline drugs, and regional disparities shaping this vital field.

New research suggests the metaverse is undergoing a correction, with projections significantly lowered. The focus is shifting away from consumer hype towards enterprise solutions driven by AR, AI, and digital twins.

The Chinese Insurance Agency 500 summit unveiled a new mentorship program aiming to elevate leadership and foster collaboration within the rapidly evolving global insurance market.

Singapore-based Strutt Inc. is challenging the personal mobility market with its ev¹—a smart vehicle integrating advanced sensing, autonomous tech, and a focus on user dignity. Awarded top honors at Red Dot and CES.

European venture capital firm Medicxi closes its fifth fund, committing €500 million to an ‘asset-centric’ model aimed at accelerating drug development and driving returns in the biotech sector.

GMEX ZERO13’s award-winning platform is tackling fragmentation & lack of trust in ESG investing with blockchain tech, potentially unlocking billions in climate finance and empowering emerging markets.

Artprice is launching an AI-powered news and data platform, claiming unprecedented accuracy and depth in art market insights. But can its proprietary approach truly deliver on the promise of 'scientific certainty'?

A new report projects the dynamic vision sensor market will nearly double in size by 2032. This technology, offering ultra-low latency and high efficiency, is set to revolutionize automation, robotics, and beyond.